A carregar...

Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate l-pipecolic acid in Escherichia coli

BACKGROUND: The six-carbon circular non-proteinogenic compound l-pipecolic acid is an important chiral drug intermediate with many applications in the pharmaceutical industry. In the present study, we developed a metabolically engineered strain of Escherichia coli for the overproduction of l-pipecol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Microb Cell Fact
Main Authors: Ying, Hanxiao, Tao, Sha, Wang, Jing, Ma, Weichao, Chen, Kequan, Wang, Xin, Ouyang, Pingkai
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369227/
https://ncbi.nlm.nih.gov/pubmed/28347340
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12934-017-0666-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!